Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;16(4):279-289.
doi: 10.1002/pmh.1539. Epub 2022 Feb 10.

The screen for cognitive impairment in psychiatry in patients with borderline personality disorder

Affiliations

The screen for cognitive impairment in psychiatry in patients with borderline personality disorder

Federica Folesani et al. Personal Ment Health. 2022 Nov.

Abstract

Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients. The Screen for Cognitive Impairment for Psychiatry (SCIP) proved to be reliable in different psychiatric populations, but it has not yet been validated in personality disorders. The purpose of this study is therefore to evaluate its psychometric properties in a sample of 58 BPD patients. The SCIP was validated against the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test A and B (TMT A and B). The receiver operator curve analysis displayed an acceptable convergent validity (total score AUC: 0.78, 95% CI: 0.70-0.86; Se: 75%, Sp: 72%). A cut-off total score of 80 identified 81% of patients as cognitively impaired. The exploratory factor analysis displayed a one-factor solution explaining 55.8% of the total variance. The SCIP displayed adequate psychometric properties in BPD and could be integrated in the routine clinical assessment to provide a preliminary evaluation of cognitive features for BPD.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests.

References

    1. Bakkour, N. , Samp, J. , Akhras, K. , El Hammi, E. , Soussi, I. , Zahra, F. , Duru, G. , Kooli, A. , & Toumi, M. (2014). Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder. Psychiatry Research, 216(3), 291–302. 10.1016/j.psychres.2014.02.014 - DOI - PubMed
    1. Baldez, D. P. , Biazus, T. B. , Rabelo‐da‐Ponte, F. D. , Nogaro, G. P. , Martins, D. S. , Kunz, M. , & Czepielewski, L. S. (2021). The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: Network meta‐analyses of randomized controlled trials. Neuroscience and Biobehavioral Reviews, 126, 265–275. 10.1016/j.neubiorev.2021.03.028 - DOI - PubMed
    1. Barcelo, F. , Sanz, M. , Molina, V. , & Rubia, F. J. (1997). The Wisconsin card sorting test and the assessment of frontal function: A validation study with event‐related potentials. Neuropsychologia, 35(4), 399–408. 10.1016/S0028-3932(96)00096-6 - DOI - PubMed
    1. Bazanis, E. , Rogers, R. D. , Dowson, J. H. , Taylor, P. , Meux, C. , Staley, C. , Nevinson‐Andrews, D. , Taylor, C. , Robbins, T. W. , & Sahakian, B. J. (2002). Neurocognitive deficits in decision‐making and planning of patients with DSM‐III‐R borderline personality disorder. Psychological Medicine, 32(8), 1395–1405. 10.1017/S0033291702006657 - DOI - PubMed
    1. Belvederi Murri, M. , Folesani, F. , Costa, S. , Biancosino, B. , Colla, C. , Zerbinati, L. , Caruso, R. , Nanni, M. G. , Purdon, S. E. , & Grassi, L. (2020a). Screening for cognitive impairment in non‐affective psychoses: A comparison between the SCIP and the MoCA. Schizophrenia Research, 218, 188–194. 10.1016/j.schres.2020.01.005 - DOI - PubMed

MeSH terms